Skip to main content
. 2013 May 23;12(9):2426–2439. doi: 10.1074/mcp.M113.027425

Table IB. B, Clinical characteristics of control subjects. (COPD) Chronic obstructive pulmonary disease, (WB) Western blot, (SRM) selected reaction monitoring.

Control num. Age/Sex Cause of the death HTN Discovery phase WB SRM
1 64/M Bilateral acute bronchopneumonia No X
2 51/F Septic shock Yes X
3 47/H Sepsis No X
4 47/F Bacterial pneumonia No X
5 47/F Carcinogenesis No X
6 34/M Acute Pancreatitis Yes X
7 64/F Bacterial Sepsis No X
8 78/F Aspiration bronchopneumonia No X
9 42/F Lymphoma No X
10 67/M Renal insufficiency No X
11 74/M COPD No X
12 87/F Carcinoma No X
13 48/F Pulmonary thromboembolism No X
14 55/M Atypical pneumonia No X
15 87/F Cholelithiasis No X
16 76/M Carcinoma No X
17 80/F Atrial fibrillation Yes X
18 49/F Respiratory insufficiency No X
19 74/M Septic shock Yes X
20 77/F COPD Yes X
Mean 69 ± 7/60%F-40%M 25,00%